144 related articles for article (PubMed ID: 10360475)
1. Effects of amifostine on cisplatin induced DNA adduct formation and toxicity in malignant glioma and normal tissues in rat.
Bergström P; Johnsson A; Bergenheim T; Henriksson R
J Neurooncol; 1999 Mar; 42(1):13-21. PubMed ID: 10360475
[TBL] [Abstract][Full Text] [Related]
2. Effects of cisplatin and amphotericin B on DNA adduct formation and toxicity in malignant glioma and normal tissues in rat.
Bergström P; Johnsson A; Cavallin-Ståhl E; Bergenheim T; Henriksson R
Eur J Cancer; 1997 Jan; 33(1):153-9. PubMed ID: 9071915
[TBL] [Abstract][Full Text] [Related]
3. Amifostine as a protector against cisplatin-induced toxicity in nude mice.
Johnsson A; Wennerberg J
Acta Oncol; 1999; 38(2):247-53. PubMed ID: 10227448
[TBL] [Abstract][Full Text] [Related]
4. The effect of dexamethasone on the uptake of cisplatin in 9L glioma and the area of brain around tumor.
Straathof CS; van den Bent MJ; Ma J; Schmitz PI; Kros JM; Stoter G; Vecht CJ; Schellens JH
J Neurooncol; 1998 Mar; 37(1):1-8. PubMed ID: 9525832
[TBL] [Abstract][Full Text] [Related]
5. cis-Diamminedichloroplatinum (II)-DNA adduct formation in renal, gonadal, and tumor tissues of male and female rats.
Reed E; Litterst CL; Thill CC; Yuspa SH; Poirier MC
Cancer Res; 1987 Feb; 47(3):718-22. PubMed ID: 3802077
[TBL] [Abstract][Full Text] [Related]
6. Persistence of platinum-ammine-DNA adducts in gonads and kidneys of rats and multiple tissues from cancer patients.
Poirier MC; Reed E; Litterst CL; Katz D; Gupta-Burt S
Cancer Res; 1992 Jan; 52(1):149-53. PubMed ID: 1727376
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin-DNA adduct formation in maternal and fetal rat tissues after transplacental cisplatin exposure.
Giurgiovich AJ; Diwan BA; Lee KB; Anderson LM; Rice JM; Poirier MC
Carcinogenesis; 1996 Aug; 17(8):1665-9. PubMed ID: 8761423
[TBL] [Abstract][Full Text] [Related]
8. Effects of the modulating agent WR2721 and its main metabolites on the formation and stability of cisplatin-DNA adducts in vitro in comparison to the effects of thiosulphate and diethyldithiocarbamate.
Treskes M; Nijtmans LG; Fichtinger-Schepman AM; van der Vijgh WJ
Biochem Pharmacol; 1992 Mar; 43(5):1013-9. PubMed ID: 1313234
[TBL] [Abstract][Full Text] [Related]
9. Influence of amifostine on the pharmacokinetics of cisplatin in cancer patients.
Korst AE; van der Sterre ML; Gall HE; Fichtinger-Schepman AM; Vermorken JB; van der Vijgh WJ
Clin Cancer Res; 1998 Feb; 4(2):331-6. PubMed ID: 9516919
[TBL] [Abstract][Full Text] [Related]
10. [Protective effect of amifostine on cisplatin-induced nephrotoxicity and its mechanism].
Guo Y; Liu Y; Xu LG; Guo MY
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):8-12. PubMed ID: 16737611
[TBL] [Abstract][Full Text] [Related]
11. Tissue injury and repair in the rat kidney after exposure to cisplatin or carboplatin.
Nonclercq D; Toubeau G; Laurent G; Tulkens PM; Heuson-Stiennon JA
Exp Mol Pathol; 1989 Oct; 51(2):123-40. PubMed ID: 2680578
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of cisplatin with and without amifostine in tumour-bearing nude mice.
Korst AE; Boven E; van der Sterre ML; Fichtinger-Schepman AM; van der Vijgh WJ
Eur J Cancer; 1998 Feb; 34(3):412-6. PubMed ID: 9640232
[TBL] [Abstract][Full Text] [Related]
13. Time dependent protection of amifostine from renal and hematopoietic cisplatin induced toxicity.
Asna N; Lewy H; Ashkenazi IE; Deutsch V; Peretz H; Inbar M; Ron IG
Life Sci; 2005 Mar; 76(16):1825-34. PubMed ID: 15698860
[TBL] [Abstract][Full Text] [Related]
14. Effect of amifostine on lipid peroxidation caused by cisplatin in rat kidney.
Bolaman Z; Koseoglu MH; Demir S; Atalay H; Akalin N; Hatip I; Aslan D
J Chemother; 2001 Jun; 13(3):337-9. PubMed ID: 11450895
[No Abstract] [Full Text] [Related]
15. Metoclopramide as a modulator of cisplatin: effects on pharmacokinetcs and cisplatin-DNA adducts in tumor and normal tissue.
Johnsson A; Kjellén E; Wennerberg J; Pero R
Anticancer Drugs; 1996 Jun; 7(4):483-8. PubMed ID: 8826617
[TBL] [Abstract][Full Text] [Related]
16. Direct amifostine effect on renal tubule cells in rats.
Weichert-Jacobsen KJ; Bannowski A; Küppers F; Loch T; Stöckle M
Cancer Res; 1999 Jul; 59(14):3451-3. PubMed ID: 10416609
[TBL] [Abstract][Full Text] [Related]
17. Reduction of cisplatin-induced nephrotoxicity in vivo by selenomethionine: the effect on cisplatin-DNA adducts.
García Sar D; Montes-Bayón M; Blanco González E; Sierra Zapico LM; Sanz-Medel A
Chem Res Toxicol; 2011 Jun; 24(6):896-904. PubMed ID: 21491944
[TBL] [Abstract][Full Text] [Related]
18. Elevated mitochondrial cisplatin-DNA adduct levels in rat tissues after transplacental cisplatin exposure.
Giurgiovich AJ; Diwan BA; Olivero OA; Anderson LM; Rice JM; Poirier MC
Carcinogenesis; 1997 Jan; 18(1):93-6. PubMed ID: 9054594
[TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines.
van de Vaart PJ; van der Vange N; Zoetmulder FA; van Goethem AR; van Tellingen O; ten Bokkel Huinink WW; Beijnen JH; Bartelink H; Begg AC
Eur J Cancer; 1998 Jan; 34(1):148-54. PubMed ID: 9624250
[TBL] [Abstract][Full Text] [Related]
20. Amifostine protective effect on cisplatin-treated rat testis.
Lirdi LC; Stumpp T; Sasso-Cerri E; Miraglia SM
Anat Rec (Hoboken); 2008 Jul; 291(7):797-808. PubMed ID: 18543292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
